Neuroprotective Effect and Possible Mechanisms of Ginsenoside-Rd for Cerebral Ischemia/Reperfusion Damage in Experimental Animal: A Meta-Analysis and Systematic Review

Ischemic stroke, the most common type of stroke, can lead to a long-term disability with the limitation of effective therapeutic approaches. Ginsenoside-Rd (G-Rd) has been found as a neuroprotective agent. In order to investigate and discuss the neuroprotective function and underlying mechanism of G...

Full description

Saved in:
Bibliographic Details
Published in:Oxidative medicine and cellular longevity 2022-09, Vol.2022, p.1-16
Main Authors: Zhou, Ai-fang, Zhu, Ke, Pu, Pei-min, Li, Zhuo-yao, Zhang, Ya-yun, Shu, Bing, Cui, Xue-jun, Yao, Min, Wang, Yong-jun
Format: Article
Language:English
Subjects:
Alzheimer's disease
Bias
Brain research
Drug dosages
Hypoxia
Ischemia
Meta-analysis
Oxidative stress
Publishing
Software
Stroke
Systematic review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Ischemic stroke, the most common type of stroke, can lead to a long-term disability with the limitation of effective therapeutic approaches. Ginsenoside-Rd (G-Rd) has been found as a neuroprotective agent. In order to investigate and discuss the neuroprotective function and underlying mechanism of G-Rd in experimental animal models following cerebral ischemic/reperfusion (I/R) injury, PubMed, Embase, SinoMed, and China National Knowledge Infrastructure were searched from their inception dates to May 2022, with no language restriction. Studies that G-Rd was used to treat cerebral I/R damage in vivo were selected. A total of 18 articles were included in this paper, and it was showed that after cerebral I/R damage, G-Rd administration could significantly attenuate infarct volume (19 studies, SMD=−1.75 −2.21 to−1.30, P10- 
ISSN:1942-0900
1942-0994
DOI:10.1155/2022/7650438